Nike Now Yields More Than Coca-Cola. Is the Turnaround Finally Priced In?

Nike’s forward (12-month) dividend yield is ~4% (vs. Coca-Cola’s 2.4%), implying the stock is priced for a limited turnaround despite continued steady payouts. The article notes a $0.41 quarterly dividend (annualized $1.64) and argues the payout is supported as free cash flow is expected to rebound from $2.2B (trailing 12-month FCF) to ~$3B in fiscal 2027, easing an elevated payout ratio. With sales roughly flat at ~$46B (down 2% currency-neutral) but performance wear improving (e.g., Nike Running up double digits for five straight quarters), it suggests margin stabilization could support a higher valuation multiple from ~1.3x sales.

Analysis

The real signal here is not the headline yield; it is that NKE is trading like a slow-growth bond proxy while its operating leverage is still intact. If inventory normalization and mix improvement translate into even 100-150 bps of gross margin recovery, EPS can inflect faster than revenue, which is why the stock can rerate from a depressed sales multiple without requiring a top-line surge. That makes the next 1-2 earnings prints more important than the trailing yield math.

Competitive dynamics favor the performance franchises, not lifestyle. A cleaner Nike line and more disciplined wholesale channel would likely pressure smaller athletic brands that rely on share gains in running and training, while also compressing the valuation premium of names that have been priced for perpetual category growth. The second-order effect is that if Nike reclaims shelf space and mindshare in running, competitors’ promo intensity rises first in North America, then margin pressure shows up in the rest of the category.

The main bear case is that the dividend becomes a narrative crutch if free cash flow does not outrun the payout over the next 4-6 quarters. A sustained miss on sell-through or another inventory rebuild would keep the multiple anchored and force the market to reprice NKE as a yield trap rather than a turnaround. The contrarian point: the stock is already cheap versus history, but not obviously cheap versus a flat-revenue, mid-single-digit FCF recovery story; upside is real, but only if margins normalize faster than consensus expects.

Key Decisions for Investors

• Initiate a small starter long in NKE on confirmation of gross margin stabilization at the next earnings release; target 15-20% upside over 6-12 months, but cut if revenue stays negative and free cash flow does not improve sequentially.
• Pair trade: long NKE / short XLY for a 3-6 month consumer-demand hedge; thesis is that NKE-specific margin recovery can outperform broader discretionary beta if the macro remains soft.
• For more direct relative value, long NKE / short UAA or ONON on any post-earnings pullback; if Nike’s performance categories keep gaining share, smaller athletic peers should feel it first in promo and shelf-space pressure.
• Set an alert on FCF versus dividend coverage for fiscal 2027 guidance; if projected FCF remains below annual distributions, reduce or exit the long, as the yield story likely turns into a value trap.